Brief radiotherapy for early prostate cancer gets high marks in preliminary trial

Ultra-hypofractionated radiation therapy for low-risk prostate cancer led to significantly lower rates of bowel and urinary dysfunction compared with patients treated with conventional radiotherapy regimens, according to a randomized trial data of two ultra-hypofractionated protocols, reported at the American Society for Radiation Oncology meeting in San Antonio.

Targeted Oncology